Common bile duct morphology is associated with recurrence of common bile duct stones in Billroth II anatomy patients.
Billroth II anatomy
Common bile duct morphology
Common bile duct stones
Endoscopic retrograde cholangiopancreatography
Recurrence
Risk factors
Journal
World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806
Informations de publication
Date de publication:
16 Sep 2021
16 Sep 2021
Historique:
received:
29
04
2021
revised:
20
06
2021
accepted:
29
07
2021
entrez:
8
10
2021
pubmed:
9
10
2021
medline:
9
10
2021
Statut:
ppublish
Résumé
Endoscopic retrograde cholangiopancreatography (ERCP) is the primary choice for removing common bile duct (CBD) stones in Billroth II anatomy patients. The recurrence of CBD stones is still a challenging problem. To evaluate CBD morphology and other predictors affecting CBD stone recurrence. A retrospective case-control analysis was performed on 138 CBD stones patients with a history of Billroth II gastrectomy, who underwent therapeutic ERCP for stone extraction at our center from January 2011 to October 2020. CBD morphology and other predictors affecting CBD stone recurrence were examined by univariate analysis and multivariate logistic regression analysis. CBD morphology ( CBD morphology, especially S type and polyline type, is associated with increased recurrence of CBD stones in Billroth II anatomy patients.
Sections du résumé
BACKGROUND
BACKGROUND
Endoscopic retrograde cholangiopancreatography (ERCP) is the primary choice for removing common bile duct (CBD) stones in Billroth II anatomy patients. The recurrence of CBD stones is still a challenging problem.
AIM
OBJECTIVE
To evaluate CBD morphology and other predictors affecting CBD stone recurrence.
METHODS
METHODS
A retrospective case-control analysis was performed on 138 CBD stones patients with a history of Billroth II gastrectomy, who underwent therapeutic ERCP for stone extraction at our center from January 2011 to October 2020. CBD morphology and other predictors affecting CBD stone recurrence were examined by univariate analysis and multivariate logistic regression analysis.
RESULTS
RESULTS
CBD morphology (
CONCLUSION
CONCLUSIONS
CBD morphology, especially S type and polyline type, is associated with increased recurrence of CBD stones in Billroth II anatomy patients.
Identifiants
pubmed: 34621818
doi: 10.12998/wjcc.v9.i26.7671
pmc: PMC8462226
doi:
Types de publication
Journal Article
Langues
eng
Pagination
7671-7681Informations de copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
Références
Endoscopy. 2015 Jul;47(7):611-6
pubmed: 25730282
Ann Transl Med. 2020 Nov;8(21):1383
pubmed: 33313128
Gastrointest Endosc. 2006 Jul;64(1):60-5
pubmed: 16813804
Gastrointest Endosc. 2018 Jan;87(1):43-57.e10
pubmed: 28756105
Gastrointest Endosc. 2008 Jun;67(7):1053-5
pubmed: 18513548
Gut. 2003 Jan;52(1):116-21
pubmed: 12477771
World J Gastroenterol. 2014 May 14;20(18):5548-56
pubmed: 24833886
World J Gastroenterol. 2013 Jun 28;19(24):3883-91
pubmed: 23840129
Endoscopy. 1999 Sep;31(7):546-9
pubmed: 10533739
Surg Obes Relat Dis. 2019 Jun;15(6):827-831
pubmed: 31113752
Obes Surg. 2016 May;26(5):990-4
pubmed: 26342481
Obes Surg. 2019 Aug;29(8):2464-2469
pubmed: 30945151
Eur J Gastroenterol Hepatol. 2006 May;18(5):461-4
pubmed: 16607138
Gastrointest Endosc. 2001 Jul;54(1):42-8
pubmed: 11427840
Endoscopy. 2017 Oct;49(10):968-976
pubmed: 28753698
Gastrointest Endosc. 2007 Dec;66(6):1154-60
pubmed: 17945223
Am J Gastroenterol. 2002 Nov;97(11):2763-7
pubmed: 12425545
Gastrointest Endosc. 1993 Jul-Aug;39(4):528-31
pubmed: 8365601
World J Gastroenterol. 2011 Sep 28;17(36):4118-23
pubmed: 22039327
J Hepatobiliary Pancreat Sci. 2016 Feb;23(2):132-6
pubmed: 26705893
Endoscopy. 2019 May;51(5):472-491
pubmed: 30943551
Gastrointest Endosc. 2015 Oct;82(4):660-5
pubmed: 25952091
Gastrointest Endosc. 2001 Sep;54(3):346-50
pubmed: 11522976
Dig Endosc. 2009 Apr;21(2):73-7
pubmed: 19691777
Gut. 1986 Oct;27(10):1193-8
pubmed: 3781333
World J Gastroenterol. 2018 Oct 21;24(39):4489-4498
pubmed: 30356997
Endoscopy. 1998 Sep;30(7):601-4
pubmed: 9826137
Gut Liver. 2012 Jan;6(1):107-12
pubmed: 22375179
N Engl J Med. 1996 Sep 26;335(13):909-18
pubmed: 8782497
Endoscopy. 2016 Jul;48(7):657-83
pubmed: 27299638
World J Gastroenterol. 2017 Aug 21;23(31):5739-5745
pubmed: 28883699
Endoscopy. 2009 Oct;41(10):849-54
pubmed: 19750447
J Gastroenterol Hepatol. 2019 Aug;34(8):1460-1466
pubmed: 30761603
World J Gastroenterol. 2019 Jan 28;25(4):485-497
pubmed: 30700944
Gastrointest Endosc. 1992 Jul-Aug;38(4):444-9
pubmed: 1511819
Endoscopy. 2002 Apr;34(4):273-9
pubmed: 11932781